MDA Founded
MDA is founded, dedicated to seeking the cause and cure for muscle diseases.
MDA is founded, dedicated to seeking the cause and cure for muscle diseases.
Boston, MA Local 718 member George Graney helps his friend, Charles Crowley – whose two sons had Duchenne Muscular Dystrophy – raise $5,000 for MDA.
The IAFF declares MDA its charity of choice with a Convention resolution.
Jerry Lewis hosts the first MDA Telethon and becomes the National Chair for MDA.
IAFF members raise $1 million for MDA.
The MDA Task Force on Drug Development is established.
IAFF members raise $3 million for MDA.
MDA-funded scientists discover Duchenne gene.
IAFF members raise $10 million for MDA.
The FDA approves the first ALS treatment.
IAFF members raise $22 million for MDA.
MDA changes the format of Labor Day Telethon – its flagship fundraising event – from a two-day marathon to a more modern six-hour production, “Show of Strength,” with high profile entertainment airing primetime on network television. The new format features a spotlight on the top fundraising IAFF locals.
MDA maintains 200 clinics, 250 research projects and summer camps for 2,600 kids.
67 clinical trials are in progress.
The IAFF celebrates 60 years of partnership with MDA.
President Schaitberger accepts the ALS Ice Bucket Challenge.
100,000 members and 1,507 locals participate in Fill the Boot. More than 3,800 kids are sent to MDA summer camp at no cost to their families.
IAFF members raise $24 million for MDA – total funds raised by the IAFF since 1954 reach more than $583 million as MDA’s largest national sponsor.
For the first time, MDA names a young adult – Joe Akmakjian – as its new National Goodwill Ambassador.
The U.S. Food and Drug Administration accelerates approval for eteplirsen, the first disease-modifying drug to treat the most common childhood form of muscular dystrophy.
Three new drugs for neuromuscular diseases are approved by the FDA.
MDA celebrates the U.S. Food and Drug Administration’s (FDA) decision to grant approval for nusinersen (brand name Spinraza), the first disease-modifying drug to treat the most common genetic cause of death in infants.
Jerry Lewis, longtime MDA national chairman, dies on August 20 at the age of 91.
The U.S. Food and Drug Administration approves deflazacort (brand name Emflaza), under development by Marathon Pharmaceuticals, to treat the most common childhood form of muscular dystrophy.
Total funds raised by the IAFF since 1954 reach more than $630 million.